CD44 and colorectal carcinoma: Mechanistically, the observed effects of silibinin could be related to its ability to transform/differentiate CD44+ population into a CD44− phenotype, as evidenced by decreased mRNA/protein levels of CD44 and the fact that silibinin increases differentiation of CRC cells in colonospheres.